News & Videos - MARRONE BIO INNOVATIONS INC.

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today the successful completion of its previously announced integration of Marrone Bio Innovations, Inc. (formerly NASDAQ: MBII) (“MBI”). “The completion of this transaction represents an important milestone in our journey, cementing our leadership in the...

Kuznicki Law PLLC is investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX). Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own. If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, contact us toll free at 833-938-0905, via email ( [email protected] ), or...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX). Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own. KSF is seeking to determine whether this consideration and the process that led to it are...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX). Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own. KSF is seeking to determine whether this consideration and the process that led to it are...

SHAREHOLDER ALERT: Weiss Law Investigates Marrone Bio Innovations, Inc. PR Newswire NEW YORK, March 18, 2022 NEW YORK , March 18, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Marrone Bio Innovations, Inc. (" Marrone Bio " or the "Company") (NASDAQ: MBII) in connection with the proposed merger of the Company with Bioceres Solutions Corp. ("Bioceres") (NASDAQ: BIOX). Under the terms of the merger...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Marrone Bio Innovations, Inc. PR Newswire NEW YORK, March 18, 2022 NEW YORK , March 18, 2022 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Marrone Bio Innovations, Inc. (NASDAQ: MBII) and its board of directors concerning the proposed acquisition of the company by Bioceres Crop Solutions Corp. (NASDAQ: BIOX). Stockholders will receive 0.088 shares of Bioceres Crop Solutions common stock for...

Thinking about buying stock in Sonnet BioTherapeutics, Nio, Farmmi, Molecular Data, or Marrone Bio Innovations? PR Newswire NEW YORK, March 17, 2022 NEW YORK , March 17, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SONN, NIO, FAMI, MKD, and MBII. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. SONN:...

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Marrone Bio Innovations, Inc. (NASDAQ: MBII) to Bioceres Crop Solutions Corp. is fair to Marrone Bio shareholders. Under the terms of the proposed transaction, each share of Marrone Bio common stock will be exchanged at closing for ordinary shares of Bioceres at a fixed ratio of 0.088. Halper Sadeh encourages Marrone Bio shareholders to click here to learn more about their legal rights and options or...

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (Bioceres) and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced today that they have entered into a definitive agreement to combine the companies in an all-stock transaction. Under the terms of the transaction, which has been unanimously approved by the Board of Directors of both companies, each share of MBI common stock will be exchanged at closing for ordinary shares of Bioceres at a fixed ratio of 0.088, representing a value of...

Thinking about buying stock in Humanigen, Marrone Bio Innovations, Grid Dynamics, Borr Drilling, or Root? PR Newswire NEW YORK, March 4, 2022 NEW YORK , March 4, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HGEN, MBII, GDYN, BORR, and ROOT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. HGEN:...

Thinking about buying stock in Marrone Bio Innovations, Village Farms, Moxian, Lucira Health, or Kadmon Holdings? PR Newswire NEW YORK, May 21, 2021 NEW YORK , May 21, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MBII, VFF, MOXC, LHDX, and KDMN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. MBII:...

Fourth Quarter 2018 Revenues Grew 72% to $5.7 Million; Fiscal Year 2018 Revenues Increased 17% to $21.2 Million Fourth Quarter 2018 Gross Margins Expanded to 50.5%; Annual Gross Margins Expanded to 48.6% DAVIS, CA / ACCESSWIRE / March 14, 2019 / Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in smart biopesticide and plant health solutions, has provided its financial results for the fourth quarter and full year ended December 31, 2018. Selected Operating and Financial...

LOS ANGELES, CA / ACCESSWIRE / January 8, 2019 / StockNewsNow.com , The Official MicroCap News Source™, today published an SNNLive Video Interview with Dr. Pamela Marrone, Founder and CEO of Marrone Bio Innovations, Inc. (NASDAQ: MBII), a provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, according to the company's website (see here: www.marronebio.com ). The video interview was recorded at the LD Micro "Main...

The Digital Issue of the Spring 2018 MicroCap Review Magazine, The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com LOS ANGELES, CA / ACCESSWIRE / April 17, 2018 / SNN Incorporated, a global multimedia financial news and publishing company focused on the MicroCap stock market, and publisher of the MicroCap Review Magazine, is pleased to announce the release of the MicroCap Review Magazine Spring 2018 issue online and in print. The Spring 2018 issue of MicroCap...

...

NEW YORK, NY / ACCESSWIRE / November 13, 2017 / Marrone Bio Innovations, Inc. (NASDAQ: MBII ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 13, 2017 at 4:30 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/22139 . To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About...

NEW YORK, NY / ACCESSWIRE / August 14, 2017 / Marrone Bio Innovations, Inc. (NASDAQ: MBII ) will be discussing their earnings results in their Q2 Earnings Call to be held on Monday, August 14, 2017 at 4:30 PM Eastern Time. To listen to the event live - visit https://www.investornetwork.com/company/22139 . Replay Information The replay will be available online at https://www.investornetwork.com/company/22139 . About Investor Network Investor Network (IN) is a financial content community, serving...

NEW YORK, NY / ACCESSWIRE / May 11, 2017 / Marrone Bio Innovations, Inc. (NASDAQ: MBII ) will be discussing their earnings results in their Q1 Earnings Call to be held May 11, 2017 at 4:30 PM Eastern Time. To listen to the event live – visit https://www.investornetwork.com/company/22139 . Replay Information The replay will be available online at https://www.investornetwork.com/company/22139 . About Investor Network Investor Network (IN) is a new financial content community, serving millions of...

DAVIS, Calif., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Richard Rominger, former Deputy Secretary of the U.S. Dept. of Agriculture and former agricultural secretary of California, emceed a 10 th anniversary luncheon celebration on October 11 for Marrone Bio Innovations, Inc. (MBI), a leading provider of effective and environmentally responsible biologically-based pest management and plant health products. Rominger is also a founding member of the Board of Directors of MBI. “I think this is the most...

DAVIS, Calif., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a leading provider of effective and environmentally responsible pest management and plant health products, announced today that the Company’s Senior Vice President of Regulatory and Government Affairs and Chief Sustainability Officer, Keith Pitts, was elected to a three year term on the Board of Directors of the trade group the Biopesticide Industry Alliance (BPIA). At MBI, Keith leads the...